-
Nicoya receives over $1.9M in funding to continue the development of a portable, saliva-based COVID-19 test
The arrival of COVID-19 vaccines has tipped the scale in favor of winning the battle against the pandemic, but the war is far from over. Diagnostic tests, along with vaccines, are required to stop out...
-
Nicoya receives over $290K in funding to develop a portable COVID-19 diagnostic test
We’re developing a solution to make COVID-19 testing accessible to everyone. Many economies around the world are in the midst of planning for their reopening, after months of global shutdowns due to...
-
Nicoya Launches Alto™, the World’s First Digital Benchtop SPR System, to Accelerate Drug Discovery
Groundbreaking new SPR system uses digital microfluidics technology and flexible 16-channel design to reduce the time and cost of drug discovery KITCHENER, ON – January 23, 2020 – Nicoya, a leadin...
-
Automated Surface Plasmon Resonance Levels the Playing Field in Protein Science
On January 20, we announced our newest product, OpenSPR-XT – a fully automated molecular analysis instrument based on the highly successful OpenSPR instrument. The release of OpenSPR-XT will provid...
